Medical Management 2: Conventional

This publication has 18 references indexed in Scilit:

• Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority Trial
  Journal of Crohn's and Colitis, 2022
• ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment
  Journal of Crohn's and Colitis, 2021
• Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis
  Cochrane Database of Systematic Reviews, 2016
• Efficacy of 5-Aminosalicylates in Crohn's Disease: Systematic Review and Meta-Analysis
  American Journal of Gastroenterology, 2011
• Clinical trial: A novel high-dose 1 g mesalamine suppository (salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis
  Inflammatory Bowel Diseases, 2010
• Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis
  Cochrane Database of Systematic Reviews, 2010
• Interventions for prevention of post-operative recurrence of Crohn's disease
  Cochrane Database of Systematic Reviews, 2009
• Budesonide for induction of remission in Crohn's disease
  2008
• Drug Insight: aminosalicylates for the treatment of IBD
  Nature Clinical Practice Gastroenterology & Hepatology, 2007
• Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis
  Digestive Diseases and Sciences, 1995